Better Therapeutics (BTTX) Competitors $0.0001 0.00 (0.00%) (As of 01:57 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends BTTX vs. AVHIW, AVHIU, ACONW, AONC, DHACW, CORBF, LFMDP, OTRKP, PIIIW, and SHCRWShould you be buying Better Therapeutics stock or one of its competitors? The main competitors of Better Therapeutics include Achari Ventures Holdings Corp. I (AVHIW), Achari Ventures Holdings Corp. I (AVHIU), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Global Cord Blood (CORBF), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), and Sharecare (SHCRW). These companies are all part of the "healthcare" industry. Better Therapeutics vs. Achari Ventures Holdings Corp. I Achari Ventures Holdings Corp. I Aclarion American Oncology Network Digital Health Acquisition Global Cord Blood LifeMD Ontrak P3 Health Partners Sharecare Better Therapeutics (NASDAQ:BTTX) and Achari Ventures Holdings Corp. I (NASDAQ:AVHIW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends, community ranking and institutional ownership. Which has preferable earnings and valuation, BTTX or AVHIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBetter TherapeuticsN/AN/A-$39.76M-$1.150.00Achari Ventures Holdings Corp. IN/AN/AN/AN/AN/A Does the MarketBeat Community favor BTTX or AVHIW? Better Therapeutics received 5 more outperform votes than Achari Ventures Holdings Corp. I when rated by MarketBeat users. CompanyUnderperformOutperformBetter TherapeuticsOutperform Votes541.67% Underperform Votes758.33% Achari Ventures Holdings Corp. IN/AN/A Do insiders & institutionals hold more shares of BTTX or AVHIW? 34.0% of Better Therapeutics shares are owned by institutional investors. 51.4% of Better Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer BTTX or AVHIW? In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled Achari Ventures Holdings Corp. I'saverage media sentiment score. Company Overall Sentiment Better Therapeutics Neutral Achari Ventures Holdings Corp. I Neutral Is BTTX or AVHIW more profitable? Company Net Margins Return on Equity Return on Assets Better TherapeuticsN/A N/A N/A Achari Ventures Holdings Corp. I N/A N/A N/A SummaryBetter Therapeutics beats Achari Ventures Holdings Corp. I on 3 of the 3 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Better Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTTX vs. The Competition Export to ExcelMetricBetter TherapeuticsHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$5,000.00$597.81M$5.10B$8.84BDividend YieldN/A1.94%5.04%4.07%P/E Ratio0.0023.6295.1214.22Price / SalesN/A4.581,217.3088.42Price / CashN/A25.4439.4936.27Price / Book0.002.866.976.37Net Income-$39.76M-$12.25M$118.73M$225.56M7 Day PerformanceN/A0.87%-1.22%-0.02%1 Month PerformanceN/A-0.56%-3.07%2.04%1 Year PerformanceN/A409.64%32.52%28.00% Better Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTTXBetter TherapeuticsN/A$0.00flatN/AN/A$5,000.00N/A0.0040Gap DownAVHIWAchari Ventures Holdings Corp. IN/A$0.01flatN/AN/A$0.00N/A0.003AVHIUAchari Ventures Holdings Corp. IN/A$10.00flatN/AN/A$0.00N/A0.003ACONWAclarionN/A$0.04+43.9%N/AN/A$0.00$49,289.000.007Gap UpAONCAmerican Oncology NetworkN/A$4.00-6.8%N/A-33.8%$0.00$1.34B0.001,520DHACWDigital Health AcquisitionN/A$0.03flatN/A+77.3%$0.00N/A0.00N/ACORBFGlobal Cord BloodN/A$1.25flatN/A+0.0%$0.00$196.12M0.001,202LFMDPLifeMDN/A$22.00flatN/A+18.9%$0.00$193.06M0.00230OTRKPOntrakN/A$0.28+0.0%N/A-11.3%$0.00$10.84M0.00250PIIIWP3 Health PartnersN/A$0.02flatN/A-88.0%$0.00$1.48B0.00500SHCRWSharecareN/A$0.09flatN/AN/A$0.00$403.73M0.003,280 Related Companies and Tools Related Companies AVHIW Alternatives AVHIU Alternatives ACONW Alternatives AONC Alternatives DHACW Alternatives CORBF Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives SHCRW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BTTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Better Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BTTX Stock Alerts